Eufilina Venosa 200 mg solución inyectable, Clariscan 0,5 mmol/mL solución inyectable EFG, Rapiscan 400 microgram solution for injection
HCB.2021.1309
Approved small_molecule active
Quick answer
Eufilina Venosa 200 mg solución inyectable, Clariscan 0,5 mmol/mL solución inyectable EFG, Rapiscan 400 microgram solution for injection for Coronary artery chronic total occlusion is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Coronary artery chronic total occlusion
- Phase
- Approved
- Modality
- small_molecule
- Status
- active